Protecting Patient Access to Integrated GI Care in the Independent Setting

In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.

January 10, 2022

Inflammatory Bowel Disease Infographic in English and Spanish

December 6, 2021

Race-Based Clinical Recommendations in Gastroenterology (AGA)

Within gastroenterology, there is a need to further examine, critique, and reconsider the use of race and ethnicity in clinical decision making. The aim of this article is to define the extent to which race and ethnicity are used in current gastroenterology guideline recommendations. The authors propose recommendations for guideline developers on considering race and […]
Continue Reading >>

January 28, 2021

DHPA Urges CMS to Rescind Ill-Conceived MFN Interim Final Rule

In a comment letter to the U.S. Centers for Medicare and Medicaid (CMS) regarding the Most Favored Nation (MFN) Interim Final Rule, DHPA wrote that the procedurally, statutorily and constitutionally flawed policy will severely restrict access to life-saving drug treatments and have adverse economic consequences for the Medicare program by shifting care from the more […]
Continue Reading >>

November 30, 2020

DHPA Opposes Most Favored Nation Rule Announced by CMS

The MFN Rule could dramatically restrict patient access to infusion medications administered in physician offices, especially for patients with Crohn’s disease and ulcerative colitis, which are both major categories of inflammatory bowel disease (IBD).
Continue Reading >>

October 16, 2020

Step Therapy Can Lead to Higher OOP Costs for Crohn’s Disease Patients (Avalere)

Avalere assessed potential implications of step therapy on patients with employer coverage to examine total OOP and payer costs. Step therapy—also known as “fail first”—is a common form of utilization management that health plans use to control costs. Step therapy requires patients to try a preferred drug before gaining access to the drug prescribed by […]
Continue Reading >>